His scientific interests lie mostly in Internal medicine, Malaria, Surgery, Artesunate and Amodiaquine. His work investigates the relationship between Internal medicine and topics such as Placebo that intersect with problems in Tolerability. His study in Malaria is interdisciplinary in nature, drawing from both Antigen and Environmental health.
His biological study spans a wide range of topics, including Visceral leishmaniasis, Leishmaniasis, Efficacy and Clinical trial. His Artesunate study combines topics in areas such as Artemether, Artemisinin and Pharmacology. His studies deal with areas such as Sulfadoxine and Mefloquine as well as Amodiaquine.
His primary areas of investigation include Malaria, Internal medicine, Artesunate, Pharmacology and Artemisinin. The Malaria study combines topics in areas such as Intensive care medicine and Environmental health. Piero Olliaro interconnects Gastroenterology, Leishmaniasis and Surgery in the investigation of issues within Internal medicine.
The study incorporates disciplines such as Artemether, Amodiaquine, Severe Malaria, Mefloquine and Sulfadoxine in addition to Artesunate. Piero Olliaro has researched Pharmacology in several fields, including Dihydroartemisinin and Drug resistance. The concepts of his Artemisinin study are interwoven with issues in Quinine, Biotechnology and Combination therapy.
Piero Olliaro mainly focuses on Global health, Internal medicine, Environmental health, MEDLINE and Malaria. His Global health study also includes fields such as
His Visceral leishmaniasis study integrates concerns from other disciplines, such as Asymptomatic and Public health. His work deals with themes such as Odds ratio, Hymenolepis nana, Mebendazole, Intestinal parasite and Anemia, which intersect with Malaria. His Mass drug administration research includes themes of Trichuris trichiura and Surgery.
His main research concerns Global health, Psychological intervention, Outbreak, Immunology and Clinical trial. His Psychological intervention study also includes
His research integrates issues of Mass drug administration, Efficacy and Monitoring and evaluation in his study of Immunology. His work carried out in the field of Clinical trial brings together such families of science as Clinical research, Medical physics, Informed consent and Cutaneous leishmaniasis. Visceral leishmaniasis is closely attributed to Internal medicine in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Artesunate combinations for treatment of malaria: meta-analysis
M Adjuik;A Babiker;P Garner;P Olliaro.
The Lancet (2004)
Averting a malaria disaster.
NJ White;F Nosten;S Looareesuwan;WM Watkins.
The Lancet (1999)
Evaluation of diagnostic tests for infectious diseases: general principles
Shabir Banoo;David Bell;Patrick Bossuyt;Alan Herring.
Nature Reviews Microbiology (2006)
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.
M. Adjuik;P. Agnamey;A. Babiker;S. Borrmann;S. Borrmann.
The Lancet (2002)
Global health security: the wider lessons from the west African Ebola virus disease epidemic
David L Heymann;Lincoln Chen;Keizo Takemi;David P Fidler.
The Lancet (2015)
Systematic review of amodiaquine treatment in uncomplicated malaria
P Olliaro;C Nevill;J LeBras;P Ringwald.
The Lancet (1996)
Epidemiology and control of human gastrointestinal parasites in children
Michael O Harhay;John Horton;Piero L Olliaro.
Expert Review of Anti-infective Therapy (2010)
Artemisinin-based combination therapy for treating uncomplicated malaria.
David Sinclair;Babalwa Zani;Sarah Donegan;Piero Olliaro.
Cochrane Database of Systematic Reviews (2009)
Chemotherapy in the Treatment and Control of Leishmaniasis
Jorge Alvar;Simon Croft;Piero Olliaro.
Advances in Parasitology (2006)
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar;Prabhat Kumar Sinha;Madhukar Rai;Deepak Kumar Verma.
The Lancet (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: